Outset Net Income From Continuing Ops from 2010 to 2024

OM Stock  USD 0.90  0.04  4.21%   
Outset Medical Net Loss yearly trend continues to be very stable with very little volatility. Net Loss is likely to drop to about -181.4 M. During the period from 2010 to 2024, Outset Medical Net Loss quarterly data regression pattern had range of 131.7 M and standard deviation of  52,135,496. View All Fundamentals
 
Net Loss  
First Reported
2019-09-30
Previous Quarter
-39.9 M
Current Value
-34.5 M
Quarterly Volatility
M
 
Covid
Check Outset Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Outset Medical's main balance sheet or income statement drivers, such as Tax Provision of 549.1 K, Interest Income of 10.7 M or Depreciation And Amortization of 4.9 M, as well as many indicators such as Price To Sales Ratio of 1.95, Dividend Yield of 0.0 or PTB Ratio of 2.29. Outset financial statements analysis is a perfect complement when working with Outset Medical Valuation or Volatility modules.
  
Check out the analysis of Outset Medical Correlation against competitors.
To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.

Latest Outset Medical's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Outset Medical over the last few years. It is Outset Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Outset Medical's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Outset Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(85,795,723)
Coefficient Of Variation(60.77)
Mean Deviation45,551,764
Median(49,780,000)
Standard Deviation52,135,496
Sample Variance2718.1T
Range131.7M
R-Value(0.86)
Mean Square Error763.5T
R-Squared0.74
Significance0.00004
Slope(10,022,764)
Total Sum of Squares38053.5T

Outset Net Income From Continuing Ops History

2024-181.4 M
2023-172.8 M
2022-163 M
2021-131.9 M
2020-121.5 M
2019-68.3 M

About Outset Medical Financial Statements

Outset Medical investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Outset Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-172.8 M-181.4 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out the analysis of Outset Medical Correlation against competitors.
To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Outset Medical. If investors know Outset will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Outset Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.74)
Revenue Per Share
2.235
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.27)
Return On Equity
(1.41)
The market value of Outset Medical is measured differently than its book value, which is the value of Outset that is recorded on the company's balance sheet. Investors also form their own opinion of Outset Medical's value that differs from its market value or its book value, called intrinsic value, which is Outset Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Outset Medical's market value can be influenced by many factors that don't directly affect Outset Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Outset Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Outset Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.